When you pick #radonc as your oncology speciality

In the new episode of #CURiEConversations on the #ACROPodcast, CURiE editor Dr. @jessschuster speaks with author Dr. Tony Song about his article, "Achieving Equity in Transportation for Radiotherapy." Listen on YouTube here (or follow Spotify or Apple): youtu.be/60uDrX5TQHI

The correct answer is B as bevacizumab has been approved in the recurrent setting🧠

The August #RadOnc Policy Update is published w/ topics including Senate Hearing Focuses on Healthcare Transparency, Healthcare CFO Study Identifies Cost and Labor Concerns & more. Here's a peek--visit acro.org/advocacy to read full issue (member log-in required). #ACROGREC

Which of the following is true about pancreatic cancer resectability criteria? 🔪 #testyourknowledgetuesday

Adding Metastasis-Directed Radiation Therapy Improves Progression-Free Survival in Oligometastatic Pancreatic Cancer 🔗 bit.ly/3YH5Vz9 “Patients with metastatic pancreatic cancer have limited treatment options and poor outcomes." #RadOnc #RadOncNews #PancreaticCancer

The latest podcast from our #ACROpolis partners QuadShot News highlights SBRT for oligometastatic pancreatic cancer, preoperative APBI, the role of post-lumpectomy mammograms prior to RT, and more: podcasts.apple.com/us/podcast/8-1…

Depends on the surgeon😉While NCCN defines borderline up to 180 on the artery, DPCG does not. No arterial involvement is a feature of resectable on both NCCN and DPCG. Given PREOPANC trials, DPCG may be more relevant but one could argue both. Answer is A urlisolation.com

Join us in collaboration with ROVERRO Register today for tips on application, interviews and more! 💥🙌 ROVER: Applying in Radiation Oncology Networking Session Registration (2024-2025) (google.com)

#MadMoneyMondays We want to highlight our outstanding ACRO grant award winners. Today Dr. Romy Joseph Magahed of University of Arkansas. He won a SEED grant for his Phase II pilot study on Pulsed Reduced Dose Rate (PRDR) for recurrent head and neck malignancies! UAMS Radiation Oncology

.NRG Oncology is seeking applications for the NRG Health Equity Fellowship. This program trains selected early-stage investigators in the NRG Oncology system by means of a structured mentorship experience. Learn more and apply by Sept 20: nrgoncology.org/Health-Equity-…

We're back #testyourknowlegetuesday 🧐Which of the following is true about managing pathologically node positive prostate after prostatectomy?

The answer is B. While it is not completely clear exactly when to use concurrent ADT in the post op setting, N+ pts are in a high risk cohort. ncbi.nlm.nih.gov In setting of PSA=0 see ARTISTIC meta analysis regarding early salvage RT v adjuvant. thelancet.com/journals/lance…

The ACRO Board of Chancellors has endorsed an Op-Ed by members TaritaThomas MD, PhD, MBA, Amulya Yalamanchili, MD and colleagues entitled, “The Physician Fee Schedule Was Not Built for High Cost Supplies and Equipment.” Read the Board statement below and view the article here: cureus.com/articles/28282…

🚨🚨SAVE THE DATE! 🚨🚨The week of 9/16 we will be hosting our panel on residency application. More information including formal date and time to be announced next week!

It's finally here!

🚨#medstudents applying #radonc ☢️ for #match2025 📩 🤔Unsure how to use program & geographical signals on ERAS?🧑‍💻 Join our all-star panel 🤩 with faculty and ACROresident ARRO as we discuss signals & 🆕 society guidelines 📝 by ARRO & ADROP 🔗👇

Today's #madmoneymonday award recognizes Dr. James Knight who recieved a GROW scholarship for travel to Cameroon Oncology Center (COC) in Bekoko, Cameroon (Feb 1-29) with a focus on feasibility and clinical implementation of novel radiation therapy techniques!

We love collaborating with our sister organizations! 👯👯‍♀️👯‍♂️

🚨Don't Let the Interview Process Frighten You🚨 Join our annual webinar for all your questions regarding the application process before you submit. SWRO ARS ROCKET🚀 Register Today! forms.gle/4T9666LHcCD4h7…